Allergy Asthma and Clinical Immunology

Papers
(The median citation count of Allergy Asthma and Clinical Immunology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Association between constipation and the development of asthma: a meta-analysis48
Hereditary angioedema with an acute attack resolved after bone marrow transplantation for acute myeloid leukemia: a case report29
Mental health problems associated with idiopathic anaphylaxis27
Long-term effectiveness and safety of lanadelumab in Canadian patients with hereditary angioedema: a subanalysis of the EMPOWER study26
Development and initial validation of a modified lymphocyte transformation test (LTT) assay in patients with DRESS and AGEP25
Upregulated expression of Notch1/4 - JAG-1/DLL-1 detected in allergic rhinitis25
Anaphylaxis24
Oral immunotherapy for the treatment of pumpkin seed allergy: a real-world case series24
One size does not fit all: uncontrolled T2 inflammation on tezepelumab—a case series23
Childhood allergic diseases across geographical regions of Kandy and Anuradhapura districts of Sri Lanka; where do the rates stand among other regions: experience from Global asthma network Phase 1 st23
The controversial effect of smoking and nicotine in SARS-CoV-2 infection23
Therapeutic potential of the topical recombinant human interleukin-1 receptor antagonist in guinea pigs with allergic rhinitis23
Oral immunotherapy improves the quality of life of adults with food allergy23
13th C1-inhibitor deficiency and angioedema workshop—202322
Seronegative immunity to SARS-CoV-2: a case study21
The cow’s milk allergy that wasn’t: allergy to supplemental oral lactase enzyme20
Correction: Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age19
Comparative effectiveness of mepolizumab and omalizumab in patients eligible for both: a retrospective cohort study18
Minimum number and types of allergens for a skin prick test panel in Thai children with allergic respiratory diseases18
Patient education in atopic dermatitis: a scoping review17
Inborn errors of immunity in adulthood16
COVID-19 risk perception and vaccine acceptance in individuals with self-reported chronic respiratory or autoimmune conditions16
Cost-effectiveness of watchful waiting versus immediate emergency department transfer after epinephrine autoinjector use in Canada15
Demographic, clinical, immunological, and molecular features of iranian national cohort of patients with defect in DCLRE1C gene14
Correction: Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real‑world study14
Duo biologic therapy using mepolizumab and omalizumab in refractory ABPA: two cases14
The efficacy and safety of stepwise oral food challenge in children with hen’s egg allergy13
Retraction Note: MicroRNA-29 mediates anti-inflammatory effects and alleviation of allergic responses and symptoms in mice with allergic rhinitis13
Two cases of dupilumab-associated conjunctivitis with high expression of IL-8 mRNA on the ocular surface: a case report13
Laying the foundation in food allergy education: CSACI food allergy educator program12
Osimertinib tolerance in a patient with Stevens Johnson syndrome during osimertinib therapy after treatment with pembrolizumab12
Comorbidities in Canadian patients with hereditary angioedema: a quantitative survey study12
Longitudinal FeNO monitoring in pediatric asthma: association of FeNO and its trajectory patterns with asthma control status12
Characterizing the symptomatology and pathophysiology of allergic rhinitis using a nasal allergen challenge model – a subset of the allergic rhinitis microbiome study12
Helicobacter pylori infection attenuates 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in C57/BL6 mice12
Associations between food allergy, country of residence, and healthcare access12
Eosinophilic gastritis and gluten-sensitive enteropathy manifested as hypoproteinemia and treated with omalizumab: a case report12
Canadian Society of Allergy and Clinical Immunology position statement: panel testing for food allergies12
Navigating primary and secondary immunodeficiency intersections: how to find IEI hidden within SID12
Anaphylaxis and loss of wheat tolerance after two weeks of wheat deprivation12
Long-term efficacy of HDM-SCIT in pediatric and adult patients with allergic rhinitis11
Severe exacerbation of facial dermatitis with swelling following introduction of abrocitinib in a patient with atopic dermatitis11
The International/Canadian hereditary angioedema guideline11
Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis11
A new way forward? Examining the potential of quantitative analysis of IgE datasets11
vACcine COnfidence amongst those living with alleRgy during the COVID pandemic (ACCORD): a scoping review protocol10
Myopericarditis following both BNT162b2 and NVX-CoV237310
Effective use of dupilumab for eosinophilic gastritis concomitant with severe asthma10
Association of fecal calprotectin level with eosinophilic gastrointestinal disease in Iranian pediatrics10
Quality of life is lower in food allergic adolescents compared to young children at a community educational symposium10
Food protein-induced enterocolitis syndrome in an infant triggered by prunes10
Assessment of multiple-opinion referrals and consults at the BC Children’s Hospital Allergy Clinic10
Severity of SARS-CoV-2 infection in children with inborn errors of immunity (primary immunodeficiencies): a systematic review10
Immunomodulatory effects of probiotic supplementation in patients with asthma: a randomized, double-blind, placebo-controlled trial10
The first successful desensitization protocol in exenatide allergy: a case report9
Effects of pre- and postnatal probiotic and ω-3 fatty acid supplementation on cytokine and chemokine responses to allergens and TLR ligands during infancy9
Non-immunoglobulin E-mediated food allergy9
Are peanut oral food challenges still useful? An evaluation of children with suspected peanut allergy, sensitization to Ara h 2 and controlled asthma9
Frey’s syndrome in an infant misdiagnosed as food allergy9
Underlying IPEX syndrome in a patient with idiopathic juvenile arthritis and vitiligo9
Successful use of dupilumab for egg-induced eosinophilic gastroenteritis with duodenal ulcer: a pediatric case report and review of literature9
Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study9
Comparison of OX40 expression in patients with multiple sclerosis and neuromyelitis optica as an approach to diagnosis9
Benralizumab for acute thromboembolism in hypereosinophilic syndrome: a case report9
Clinical manifestation for immunoglobulin A deficiency: a systematic review and meta-analysis9
The role of skin testing, drug challenge and IFN-γ ELISpot in delayed hypersensitivity to iodinated contrast media9
Isolated goat and sheep milk allergy in an adult in the absence of bovine sensitization8
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) caused by niraparib: a novel antineoplastic agent8
Gender and geographic representation in editorial boards of allergy and immunology journals8
Infusion parameters, safety, and practical guidance for the manual administration of subcutaneous immunoglobulin 20% (Ig20Gly)8
The prevalence of gastrointestinal symptoms and cobalamin deficiency in patients with chronic urticaria8
Prurigo Nodularis onset during secukinumab treatment of psoriasis: a case report8
CMV retinitis in patients on mycophenolate immunosuppression: a report of two cases8
Inhaled corticosteroids do not affect the antibody titer against the SARS-CoV-2 spike protein in BNT162b2 mRNA vaccinated patients8
Unrecognized ciliary motility disorders in neutrophilic severe asthma exacerbations8
fSCIG 10% in pediatric primary immunodeficiency diseases: a European post-authorization safety study8
The association between early formula and reduced risk of cow’s milk allergy during the first three year of life: a Japanese cohort study7
Attack rate reductions following berotralstat initiation among US patients with hereditary angioedema in the real-world7
Beyond first sip: combination of intermittent cow’s milk exposure and atopic dermatitis associated with severe IgE mediated cow’s milk reactions—a retrospective study7
The value of clinical observation: sleuthing for allergies on the front lines7
Resource utilization and cost assessment of a proactive penicillin allergy de-labeling program for low-risk inpatients7
A survey of severe asthma in Canada: results from the CASCADE practice reflective program7
Accelerometer-derived sleep metrics in mild and difficult-to-treat asthma7
Technical validation of controlled exposure to cat dander in the specialized particulate control environmental exposure unit (SPaC-EEU)7
Knowledge, attitudes, and practices toward food allergies among early childhood educators in Taiwan: a cross-sectional study7
Evaluating the efficacy of a novel home-based oral food challenge protocol for pediatric food protein induced enterocolitis syndrome7
Recommendations from a Canadian Delphi consensus study on best practice for optimal referral and appropriate management of severe asthma7
Evaluation of adherence to guideline-directed therapy and risk factors for exacerbation in mild asthma: a retrospective chart review7
The acuity of paediatric asthma in the emergency department worsened after the COVID-19 pandemic in Alberta, Canada7
Cow’s milk allergy skin tests: fresh milk, commercial extracts, or both?7
Baseline disease duration of chronic spontaneous urticaria participants in phase III clinical trials6
Prevalence trends and risk factors for allergic rhinoconjunctivitis, asthma and eczema in the UK6
Sublingual immunotherapy for allergy to shrimp: the nine-year clinical experience of a Midwest Allergy-Immunology practice6
Medication-related perceptions of children and adolescents with severe asthma and moderate-to-severe atopic dermatitis: a non-interventional exploratory study6
Treatment with pollen allergen immunotherapy improves health-related quality of life in children and adolescents: a three-year follow-up-study6
Anxiety in adults with asthma during the coronavirus disease 2019 pandemic: a Canadian perspective6
Introduction of a penicillin allergy de-labelling program with direct oral challenge and its effects on utilization of beta-lactam antimicrobials: a multicenter retrospective parallel cohort study6
Effectiveness of immunoglobulin replacement therapy in preventing infections in patients with chronic obstructive pulmonary disease: a systematic review6
Clinical validation of controlled exposure to cat dander in the Specialized Particulate Control Environmental Exposure Unit (SPaC-EEU)6
Effects of sublingual immunotherapy for dust mite on Th 17 / Treg cells in children with asthma6
Characterizing drug allergy management among allergists in Canada: a national survey study6
Presence of variable extrathoracic airflow limitation in patients with a negative methacholine challenge test6
Hypersensitivity reactions to folinic acid: mechanisms involved based on two case reports and a literature review6
Early introduction is not enough: CSACI statement on the importance of ongoing regular ingestion as a means of food allergy prevention6
Long term longitudinal follow-up of an AD-HIES cohort: the impact of early diagnosis and enrollment to IPINet centers on the natural history of Job’s syndrome6
Three cases of jackfruit allergy in Canada: a case series6
Different expression levels of interleukin-36 in asthma phenotypes6
Management of type 1 immediate hypersensitivity reactions to antituberculosis drug: succesful desensitization6
Declining venom immunotherapy: patient characteristics and clinical outcomes5
Knowledge assessment tools in atopic dermatitis patient education: a scoping review5
Correction: The complexities of decision-making associated with on-demand treatment of hereditary angioedema (HAE) attacks5
Abstracts of the 14th C1-inhibitor Deficiency and Angioedema Workshop5
Avapritinib reduces symptoms and mast cell burden in systemic mastocytosis5
Retraction Note: Clinical and immuno-proteomic approach on lantana camara pollen allergy—a major health hazard5
Physician education on World Asthma Day aids in disease management during the COVID-195
Parent perspectives on guided self-care approaches to ensure timely access to therapy in infants with food allergy5
Delayed presentation of food protein-induced enterocolitis syndrome (FPIES) to okra in a toddler5
Serum autophagy protein 5 is positively related to T helper 2/T helper 1 ratio, inflammation, and exacerbation in adult asthma patients5
Immunoglobulin utilization in Canada: a comparative analysis of provincial guidelines and a scoping review of the literature5
Early-life antibiotics and childhood allergy: a multi-center cohort5
Angioedema5
Successful dupilumab treatment in a patient with severe dermatitis following allogenic hematopoietic stem cell transplantation5
No impact of helminth coinfection in patients with smear positive tuberculosis on immunoglobulin levels using a novel method measuring Mycobacterium tuberculosis-specific antibodies5
Genetic links between atopy, allergy, and alopecia areata: insights from a Mendelian randomization study5
Eosinophilic esophagitis5
Efficacy of Omalizumab against Japanese Cedar pollinosis in clinical practice5
Pediatric emergency department-based asthma education tools and parent/child asthma knowledge4
Allergen immunotherapy4
Asymptomatic surveillance testing for COVID-19 in health care professional students: lessons learned from a low prevalence setting4
Recommendations for the diagnosis and management of eosinophilic esophagitis in adults and children in Canada: a Delphi consensus project4
Parental perceptions of a novel subsidy program to address the financial burden of milk allergy: a qualitative study4
Efficacy and safety of the tree sublingual immunotherapy tablet in the subpopulation of Canadian children with allergic rhinitis and/or conjunctivitis: phase III trial results4
A case of possible anaphylaxis to ASA and structurally unrelated NSAIDs4
Immunomodulatory effects of modified Liu-Wei-Di-Huang-Wan Traditional Chinese medicine on allergic asthmatic mice4
A clinician’s guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases4
Exploratory pharmacodynamics and efficacy of PF-06817024 in a Phase 1 study of patients with chronic rhinosinusitis and atopic dermatitis4
Developing and disseminating an electronic penicillin allergy de-labelling tool using the model for improvement framework4
Authorship gender diversity in Allergy and Immunology: analysis of articles published in the Canadian journal of Allergy, Asthma & Clinical Immunology4
Development of a primary care screening algorithm for the early detection of patients at risk of primary antibody deficiency4
Fatal eosinophilic myocarditis and submassive hepatic necrosis in lamotrigine induced DRESS syndrome4
PRevalence of the Eosinophilic Phenotype Among SeveRE asthma patients in Lebanon: results of the PREPARE study4
Safety and adherence of early oral immunotherapy for peanut allergy in a primary care setting: a retrospective cross-sectional study4
Inborn errors of immunity (primary immunodeficiencies)4
Clinical outcomes of dupilumab therapy in chronic rhinosinusitis with nasal polyps in a Canadian tertiary care rhinology practice4
Impact of a standardized emergency department asthma care pathway on health services utilization4
“There definitely should be some more help for families”: a call for federal support for families managing pediatric food allergy4
Autoinflammatory gene mutations associated with eosinophilia and asthma4
Systemic lupus erythematosus with various clinical manifestations in a patient with hereditary angioedema: a case report4
Eosinophil-independent IL-5 levels are increased in critically ill COVID-19 patients who survive4
“Vegan” and “plant-based” claims: risk implications for milk- and egg-allergic consumers in Canada4
Update on the association between Helicobacter pylori infection and asthma in terms of microbiota and immunity3
Mepolizumab reduces healthcare resource utilization in patients with chronic rhinosinusitis with nasal polyps: a linked EMR and claims-based pre-post study3
A qualitative study of the impact of the COVID-19 pandemic on healthcare access and service delivery for people living with chronic obstructive pulmonary disease and asthma3
This supplement is dedicated to the late Dr. Richard Warrington3
Management of a patient with common variable immunodeficiency and hepatopathy3
Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization3
Correlations between IL-36 family cytokines in peripheral blood and subjective and objective assessment results in patients with allergic rhinitis3
IL-1β and iNOS can drive the asthmatic comorbidities and decrease of lung function in perennial allergic rhinitis children3
Estimation of short-course systemic corticosteroid risks on adverse outcomes in childhood asthma3
Real-world association between systemic corticosteroid exposure and complications in US patients with severe asthma3
The unique diagnostic and management challenge of a patient with concomitant anti-interferon-gamma autoantibody associated immunodeficiency syndrome, IgG4-related disease, and treatment refractory, di3
A rare immunological disease, caspase 8 deficiency: case report and literature review3
Diagnosis and management of mast cell activation syndrome (MCAS) in Canada: a practical approach3
Introduction to immunology and immune disorders3
A real-world evaluation of the effectiveness and Sufficiency of Current Emergency Department Preventative Strategies for Reducing Emergency Department revisits in a Canadian children’s hospital: a ret3
Two-stage association study of mitochondrial DNA variants in allergic rhinitis3
Focused allergic rhinitis practice parameter for Canada3
Consensus on the management of united airways disease with type 2 inflammation: a multidisciplinary Delphi study3
Eosinophil count testing in patients with asthma varies by healthcare provider type in the US: a retrospective study3
Secondary Immunodeficiency3
Pediatric anaphylaxis: age-related symptom trends and the limited role of allergen molecules: a retrospective analysis3
Rare and heterogeneous manifestations of leucocyte adhesion deficiency type 1: report of two cases with diagnostic dilemmas and novel ITGB2 mutation3
Low immunoglobulin levels affect the course of COPD in hospitalized patients3
Immune endotyping and gene expression profile of patients with chronic rhinosinusitis with nasal polyps in the aspirin-exacerbated respiratory disease (AERD) and the non-AERD subgroups3
Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases3
Shared genetic investigation of asthma and blood eosinophils in relation to chronic rhinosinusitis3
Zéro allergie research clinic: a clinical and research initiative in oral immunotherapy for managing IgE-mediated food allergy3
Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real-world study3
High total serum IgE level at diagnosis was associated with a progressive decline in lung function in asthmatic patients with allergic bronchopulmonary mycosis3
Prevalence of reported food allergies in Brazilian preschoolers living in a small Brazilian city3
Barriers to penicillin allergy de-labeling in the inpatient and outpatient settings: a qualitative study3
Winnipeg-based elementary school teachers’ perspectives on food allergy management: a qualitative analysis3
Oral corticosteroid overexposure: characterizing oral corticosteroid use in patients with chronic rhinosinusitis with nasal polypS in Canada (ACTIONS) results3
Oral and nasal provocation test in chicken egg allergy—case report3
Long-term efficacy of anti-IL-4 receptor antibody in a patient with aspirin-exacerbated respiratory disease and IgG4-related disease3
0.26931285858154